Bhatt DL - Search Results

1

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.

Marso SP, Lincoff AM, Ellis SG, Bhatt DL, Tanguay JF, Kleiman NS, Hammoud T, Booth JE, Sapp SK, Topol EJ. Marso SP, et al. Among authors: bhatt dl. Circulation. 1999 Dec 21-28;100(25):2477-84. doi: 10.1161/01.cir.100.25.2477. Circulation. 1999. PMID: 10604884 Clinical Trial.

2

Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention.

Bhatt DL, Lincoff AM, Kereiakes DJ, Tcheng JE, Simoons ML, van der Wieken LR, Godfrey N, Califf RM, Topol EJ. Bhatt DL, et al. Am J Cardiol. 1998 Nov 1;82(9):1105-6, A6. doi: 10.1016/s0002-9149(98)00565-7. Am J Cardiol. 1998. PMID: 9817488

3

Direct myocardial revascularization and angiogenesis--how many patients might be eligible?

Mukherjee D, Bhatt DL, Roe MT, Patel V, Ellis SG. Mukherjee D, et al. Among authors: bhatt dl. Am J Cardiol. 1999 Sep 1;84(5):598-600, A8. doi: 10.1016/s0002-9149(99)00387-2. Am J Cardiol. 1999. PMID: 10482164 Clinical Trial.

4

Corrected TIMI frame count does not predict 30-day adverse outcomes after reperfusion therapy for acute myocardial infarction.

Bhatt DL, Ellis SG, Ivanc TB, Crowe T, Balazs E, Debowey D, Pangerl A, Chew PH. Bhatt DL, et al. Am Heart J. 1999 Oct;138(4 Pt 1):785-90. doi: 10.1016/s0002-8703(99)70197-3. Am Heart J. 1999. PMID: 10502228 Clinical Trial.

5

Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease.

Bhatt DL, Topol EJ. Bhatt DL, et al. Med Clin North Am. 2000 Jan;84(1):163-79, ix. doi: 10.1016/s0025-7125(05)70212-1. Med Clin North Am. 2000. PMID: 10685133 Review.

6

Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ. Bhatt DL, et al. J Am Coll Cardiol. 2000 Mar 15;35(4):922-8. doi: 10.1016/s0735-1097(99)00650-6. J Am Coll Cardiol. 2000. PMID: 10732889 Free article.

7

The benefit of abciximab in percutaneous coronary revascularization is not device-specific.

Bhatt DL, Lincoff AM, Califf RM, Simoons ML, Tcheng JE, Brener SJ, Wolski KE, Topol EJ. Bhatt DL, et al. Am J Cardiol. 2000 May 1;85(9):1060-4. doi: 10.1016/s0002-9149(00)00696-2. Am J Cardiol. 2000. PMID: 10781752

8

Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators.

Bhatt DL, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Bhatt DL, et al. Am Heart J. 2000 Jul;140(1):67-73. doi: 10.1067/mhj.2000.108239. Am Heart J. 2000. PMID: 10874265 Clinical Trial.

9

Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions.

Cura FA, Bhatt DL, Lincoff AM, Kapadia SR, L'Allier PL, Ziada KM, Wolski KE, Moliterno DJ, Brener SJ, Ellis SG, Topol EJ. Cura FA, et al. Among authors: bhatt dl. Circulation. 2000 Jul 4;102(1):28-34. doi: 10.1161/01.cir.102.1.28. Circulation. 2000. PMID: 10880411 Clinical Trial.

10

Is the corrected TIMI frame count an independent predictor of adverse outcome?

Bhatt DL, Ellis SG. Bhatt DL, et al. Circulation. 2000 Jul 11;102(2):E19. doi: 10.1161/01.cir.102.2.e19. Circulation. 2000. PMID: 10889146 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,182 results

Search Page

Filters